Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agents
Author:
Affiliation:
1. Jiangsu Key Laboratory of Drug Design & Optimization, China Pharmaceutical University, Nanjing, 210009, China
2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
Abstract
Publisher
Future Science Ltd
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.future-science.com/doi/pdf/10.4155/fmc-2016-0129
Reference152 articles.
1. ANIMAL CELL CYCLES AND THEIR CONTROL
2. To cycle or not to cycle: a critical decision in cancer
3. How the Cyclin Became a Cyclin
4. Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages
5. Cyclin-dependent kinases: a family portrait
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Activity tracking isolation of Gelsemium elegans alkaloids and evaluation of their antihuman gastric cancer activity in vivo;Chinese Journal of Analytical Chemistry;2021-12
2. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer;Scientific Reports;2021-09-09
3. Small-molecule PROTACs: novel agents for cancer therapy;Future Medicinal Chemistry;2020-05
4. CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?;Journal of Medicinal Chemistry;2020-03-09
5. Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity;Journal of Medicinal Chemistry;2020-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3